CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-11 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 36,569 |
| 2025-11-10 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-11-10 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −19,900 | $68.71 | $1.4M | 733,819 |
| 2025-11-10 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −100 | $69.30 | $7K | 733,719 |
| 2025-11-10 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 56,569 |
| 2025-11-10 | Connaughton Bernadette Director | Sale 10b5-1 | −2,000 | $68.48 | $137K | 42,952 |
| 2025-11-01 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Option exercise | +9,326 | 17,000 | ||
| 2025-11-01 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Sale | −4,263 | $65.19 | $278K | 12,737 |
| 2025-11-01 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Option exercise · Restricted Stock Units | −9,326 | 18,651 | ||
| 2025-10-03 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Grant or award · Option to Purchase Common Stock | +9,031 | 9,031 | ||
| 2025-10-03 | Caudill Cortney SVP, CHIEF OPERATING OFFICER | Grant or award · Restricted Stock Units | +3,625 | 3,625 | ||
| 2025-10-03 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-10-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −14,235 | $68.47 | $975K | 739,484 |
| 2025-10-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,334 | $69.83 | $163K | 737,150 |
| 2025-10-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,707 | $70.58 | $191K | 734,443 |
| 2025-10-03 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −724 | $71.67 | $52K | 733,719 |
| 2025-10-03 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 76,569 |
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −6,600 | $70.51 | $465K | 747,119 |
| 2025-10-02 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −10,200 | $71.28 | $727K | 736,919 |
Page 14 of 26 · 513 trades